Hepatic Fas Protein Expression Might Be a Predictive Factor for Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis C Undergoing Interferon Therapy-Reference-Cited by-同舟云学术

Hepatic Fas Protein Expression Might Be a Predictive Factor for Hepatocellular Carcinoma Development in Patients With Chronic Hepatitis C Undergoing Interferon Therapy

Published:2002-03 Issue:3 Volume:34 Page:263-267
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:Journal of Clinical Gastroenterology

Author:

Hirashima Noboru,Matsumoto Yoshihiro,Ohono Tomoyoshi,Kimura Yoshihide,Hasegawa Izumi,Ueda Ryuzo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference37 articles.

1. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

2. Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon

3. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

4. Recombinant Interferon Alfa Therapy for Chronic Hepatitis C

5. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies;Scientific Reports;2023-03-01

2. The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma;Hepatitis Monthly;2012-11-30

3. Characterization of chronic HCV infection-induced apoptosis;Comparative Hepatology;2011-07-23

4. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation;Journal of Viral Hepatitis;2009-11-17

5. Clinical Significance of Serum Soluble Fas, Fas Ligand and Fas in Intrahepatic Lymphocytes in Chronic Hepatitis C;Immunological Investigations;2008-01